Table 2.
Mohammadi Ardehali et al. [76] | Nicolai et al. [77] | |
---|---|---|
Number of patients | 47 | 46 |
Mean age (years) | 17.1 (7–37) | 17 (10–35) |
Previous treatment | 16 | 5 |
(IA) 5 | (IA) 3 | |
(IB) 10 | (IB) 1 | |
Stage (Radkowski classification) | (IIA) 3 | (IIA) 5 |
(IIB) 3 | (IIB) 10 | |
(IIC) 22 | (IIC) 19 | |
(IIIA) 3 | (IIIA) 7 | |
(IIIB) 1 | (IIIB) 1 | |
Preoperative embolization | 5 | 40 |
Mean blood loss (mL) | 1336.2 (300–8500) | 580 (250–1300) |
Mean hospitalization time (days) |
3.1 | 5 |
Mean followup (months) | 33.1 | 73 |
Persistence rate (%) | 19.1 | 8.6 |